Erratum: FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization (Nature Communications 6 (7079) DOI: 10.1038/ncomms8079);FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization

Nature Communications

Volumn 6, Issue , 2015, Pages

  O Sullivan, Insug ^a   Zhang, Wenwei ^a   Wasserman, David H ^b   Liew, Chong Wee ^a   Liu, Jonathan ^a   Paik, Jihye ^c   Depinho, Ronald A ^c   Stolz, Donna Beer ^d   Kahn, C Ronald ^e   Schwartz, Michael W ^f   Unterman, Terry G ^a,g  

^a UNIVERSITY OF ILLINOIS   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; INSULIN RECEPTOR; MESSENGER RNA; PROTEIN KINASE B; PYRUVATE DEHYDROGENASE KINASE 4; TRANSCRIPTION FACTOR FKHR; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE;

GENE EXPRESSION; GLUCOSE; INHIBITION; METABOLISM; PEPTIDE; PROTEIN; RODENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MALE; MOUSE; NONHUMAN; WESTERN BLOTTING; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE CLAMP TECHNIQUE; LIVER; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; FORKHEAD BOX PROTEIN O1; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; INSULIN; LIVER; MALE; MICE;

EID: 84929190974     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8861     Document Type: Erratum

References (32)

1. Defronzo, R. A. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 58, 773-795 (2009).
2. Zhang, W. et al. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J. Biol. Chem. 281, 10105-10117 (2006).
3. Zhang, K. et al. Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice. Endocrinology 153, 631-646 (2012).
4. Haeusler, R. A., Kaestner, K. H. & Accili, D. FoxOs function synergistically to promote glucose production. J. Biol. Chem. 285, 35245-35248 (2010).
5. Xiong, X., Tao, R., DePinho, R. A. & Dong, X. C. Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis. PloS ONE 8, e74340 (2013).
6. Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868 (1999).
7. Schmoll, D. et al. Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J. Biol. Chem. 275, 36324-36333 (2000).
8. Hall, R. K. et al. Regulation of phosphoenolpyruvate carboxykinase and insulinlike growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J. Biol. Chem. 275, 30169-30175 (2000).
9. Puigserver, P. et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423, 550-555 (2003).
10. Matsumoto, M., Han, S., Kitamura, T. & Accili, D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J. Clin. Invest. 116, 2464-2472 (2006).
11. Dong, X. C. et al. Inactivation of hepatic Foxo1 by insulin signalling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab. 8, 65-76 (2008).
12. Lu, M. et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat. Med. 18, 388-395 (2012).
13. Cheng, Z. &White, M. F. The AKTion in non-canonical insulin signalling. Nat. Med. 18, 351-353 (2012).
14. Cheng, Z. et al. Foxo1 integrates insulin signalling with mitochondrial function in the liver. Nat. Med. 15, 1307-1311 (2009).
15. LeRoith, D. & Yakar, S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nature clinical practice. Endocrinol. Metab. 3, 302-310 (2007).
16. Michael, M. D. et al. Loss of insulin signalling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6, 87-97 (2000).
17. Schaffer, L. et al. A novel high-affinity peptide antagonist to the insulin receptor. Biochem. Biophys. Res. Commun. 376, 380-383 (2008).
18. Liang, G. et al. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J. Biol. Chem. 277, 9520-9528 (2002).
19. Wu, P. et al. Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues. Arch. Biochem. Biophys. 381, 1-7 (2000).
20. Kwon, H. S., Huang, B., Unterman, T. G. & Harris, R. A. Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors. Diabetes 53, 899-910 (2004).
21. Titchenell, P.M., Chu, Q., Monks, B.R. & Birnbaum, M.J. Hepatic insulin signaling is dispensable for suppression of glucose output by insulin in vivo. Nat. Commun. (2015) doi:10.1038/ncomms8078.
22. Mittelman, S. D., Fu, Y. Y., Rebrin, K., Steil, G. & Bergman, R. N. Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J. Clin. Invest. 100, 3121-3130 (1997).
23. Ramnanan, C. J., Edgerton, D. S. & Cherrington, A. D. Evidence against a physiologic role for acute changes in CNS insulin action in the rapid regulation of hepatic glucose production. Cell Metab. 15, 656-664 (2012).
24. Haeusler, R. A. et al. Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors. Nat. Commun. 5, 5190 (2014).
25. Rebrin, K., Steil, G. M., Getty, L. & Bergman, R. N. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44, 1038-1045 (1995).
26. Lewis, G. F., Vranic, M., Harley, P. & Giacca, A. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes 46, 1111-1119 (1997).
27. El Ouaamari, A. et al. Liver-derived systemic factors drive beta cell hyperplasia in insulin-resistant states. Cell Rep. 3, 401-410 (2013).
28. Paik, J. H. et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128, 309-323 (2007).
29. Ayala, J. E., Bracy, D. P., McGuinness, O. P. & Wasserman, D. H. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55, 390-397 (2006).
30. Berglund, E. D. et al. Glucose metabolism in vivo in four commonly used inbred mouse strains. Diabetes 57, 1790-1799 (2008).
31. Kang, L. et al. Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin alpha2beta1 in mice. Diabetes 60, 416-426 (2011).
32. Wu, P. et al. Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. Biochem. J. 329(Pt 1): 197-201 (1998).